Table 3—

Malignancy post-lung transplantation for adults. Cumulative prevalence in survivors (follow-ups: April 1994–June 2002)

Malignancy1-yr survivors5-yr survivors
No malignancy5104 (96.1)886 (86.9)
Malignancy (all types combined)209 (3.9)134 (13.1)
Malignancy type
 Skin4461
 Lymph10921
 Other3532
 Lymph+skin3
 Lymph+other5
 Skin+other2
 Type not reported2110
  • Data are presented as n (%)

  • Adapted with permission from 17